设计和原型的TOMO:一个应用程序,以改善耐药结核病治疗的坚持
Anis Fuad1,2, Guntur Budi Herwanto3, Ariani Arista Putri Pertiwi4
1Department of Biostatistics, Epidemiology and Population Health, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Yogyakarta, 55284, Indonesia.
F1000Research
|September 5, 2024
概括
开发了一个新的Android应用程序TOMO,以改善多药耐药结核病 (MDR-TB) 患者的药物坚持. 这种数字健康干预提供了提醒和不良事件跟踪等功能,以支持复杂的治疗方案.
科学领域:
- 数字健康数字健康
- 移动健康应用 移动健康应用
- 结核病治疗的坚持 结核治疗的坚持
背景情况:
- 耐药性和多耐药性结核病 (DR/MDR-TB) 由于复杂的治疗方案,显著挑战治疗坚持.
- 终结结核病战略促进数字健康解决方案,以打击结核病.
- 智能手机的普及为结核病护理中的移动健康干预提供了机会.
研究的目的:
- 详细介绍TOMO Android应用程序的开发过程.
- 介绍TOMO应用程序的架构和功能.
- 解决数字健康工具的需求,以改善耐多药结核病药物治疗的依从性.
主要方法:
- 采用了设计思维过程,涉及关键利益相关者,包括MDR-TB转诊中心,卫生办公室,初级卫生中心和患者.
- 数字发展原则指导了应用程序的设计和创作.
- 功能来源于印度尼西亚卫生部的MDR-TB治疗指南.
主要成果:
- TOMO应用程序是为患者,初级卫生中心,临床团队和病例管理人员设计的.
- 关键功能包括药物坚持提醒,不良事件记录和报告,以及患者病例经理沟通.
- 在四个用例中进行了成功的测试:高坚持,低坚持,不良事件和基于初级卫生中心的治疗.
结论:
- 图莫应用程序对数字卫生干预措施的文献做出了贡献,以改善MDR-TB的遵守.
- 该应用程序的功能已经通过基于场景的测试来验证.
- 在实际实施之前,计划进行进一步的可用性测试.
相关概念视频
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Structure-Activity Relationships and Drug Design
679
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
679
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418


